Nifty
Sensex
:
:
24793.25
81361.87
-18.80 (-0.08%)
-82.79 (-0.10%)

Chemicals

Rating :
67/99

BSE: 530019 | NSE: JUBLPHARMA

1126.70
19-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1128.1
  •  1148
  •  1116.9
  •  1123.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  411715
  •  466222120.7
  •  1309.9
  •  701.8

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 17,944.61
  • 21.38
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 19,292.71
  • 0.44%
  • 2.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.28%
  • 17.74%
  • FII
  • DII
  • Others
  • 17.23%
  • 5.02%
  • 6.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.41
  • -6.04
  • 3.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.53
  • -14.29
  • -4.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -17.06
  • -38.80
  • -42.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.30
  • 15.23
  • 25.33

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.01
  • 1.82
  • 1.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.79
  • 10.49
  • 12.24

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
4.87
52.7
34.83
47.63
P/E Ratio
231.36
21.38
32.35
23.66
Revenue
6703
7192
7959
8904
EBITDA
901
1174
1323
1622
Net Income
77
839
553
754
ROA
0.7
6.9
0
0.1
P/B Ratio
7.56
2.87
2.71
2.45
ROE
1.42
14.36
8.53
10.67
FCFF
-144
-241
-52
349
FCFF Yield
-0.73
-1.22
-0.27
1.78
Net Debt
2707
1642
BVPS
149.05
392.7
415
459.2

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
1,928.80
1,758.60
9.68%
1,821.70
1,677.10
8.62%
1,752.30
1,680.30
4.28%
1,731.70
1,586.90
9.12%
Expenses
1,583.40
1,487.20
6.47%
1,534.30
1,459.10
5.15%
1,462.90
1,438.50
1.70%
1,480.20
1,417.30
4.44%
EBITDA
345.40
271.40
27.27%
287.40
218.00
31.83%
289.40
241.80
19.69%
251.50
169.60
48.29%
EBIDTM
17.91%
15.43%
15.78%
13.00%
16.52%
14.39%
14.52%
10.69%
Other Income
11.90
14.40
-17.36%
9.20
35.80
-74.30%
21.70
9.90
119.19%
14.00
8.60
62.79%
Interest
52.70
73.00
-27.81%
55.60
71.30
-22.02%
61.00
66.10
-7.72%
71.00
61.90
14.70%
Depreciation
95.20
101.00
-5.74%
91.30
94.60
-3.49%
91.40
96.60
-5.38%
90.70
89.70
1.11%
PBT
206.10
-57.10
-
130.80
87.90
48.81%
144.50
89.00
62.36%
499.70
26.60
1,778.57%
Tax
54.70
8.10
575.31%
29.80
34.60
-13.87%
41.90
35.90
16.71%
17.90
19.20
-6.77%
PAT
151.40
-65.20
-
101.00
53.30
89.49%
102.60
53.10
93.22%
481.80
7.40
6,410.81%
PATM
7.85%
-3.71%
5.54%
3.18%
5.86%
3.16%
27.82%
0.47%
EPS
9.72
-3.71
-
6.39
4.23
51.06%
6.51
3.96
64.39%
30.51
0.41
7,341.46%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
7,234.50
6,702.90
6,281.70
6,130.16
6,098.53
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
Net Sales Growth
7.93%
6.71%
2.47%
0.52%
-33.38%
0.48%
21.19%
28.26%
1.95%
-1.32%
 
Cost Of Goods Sold
2,317.00
2,140.70
1,877.90
1,488.01
1,536.01
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
Gross Profit
4,917.50
4,562.20
4,403.80
4,642.16
4,562.52
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
GP Margin
67.97%
68.06%
70.11%
75.73%
74.81%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
Total Expenditure
6,060.80
5,802.10
5,505.50
4,973.83
4,702.07
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
Power & Fuel Cost
-
148.90
166.70
134.30
105.79
112.21
466.38
424.91
333.66
366.71
393.04
% Of Sales
-
2.22%
2.65%
2.19%
1.73%
1.23%
5.12%
5.65%
5.69%
6.38%
6.75%
Employee Cost
-
2,216.00
2,166.00
2,043.39
1,922.88
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
% Of Sales
-
33.06%
34.48%
33.33%
31.53%
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
Manufacturing Exp.
-
523.20
581.10
562.32
449.40
362.15
552.26
485.98
428.84
436.46
432.40
% Of Sales
-
7.81%
9.25%
9.17%
7.37%
3.96%
6.06%
6.46%
7.32%
7.59%
7.42%
General & Admin Exp.
-
475.00
464.10
432.34
387.92
416.80
540.75
354.56
280.98
256.23
302.28
% Of Sales
-
7.09%
7.39%
7.05%
6.36%
4.55%
5.94%
4.72%
4.79%
4.46%
5.19%
Selling & Distn. Exp.
-
214.30
161.60
209.71
177.15
194.71
267.70
247.85
185.79
135.54
203.98
% Of Sales
-
3.20%
2.57%
3.42%
2.90%
2.13%
2.94%
3.30%
3.17%
2.36%
3.50%
Miscellaneous Exp.
-
84.00
88.10
103.77
122.93
853.22
96.92
67.76
53.20
65.96
203.98
% Of Sales
-
1.25%
1.40%
1.69%
2.02%
9.32%
1.06%
0.90%
0.91%
1.15%
0.68%
EBITDA
1,173.70
900.80
776.20
1,156.33
1,396.46
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
EBITDA Margin
16.22%
13.44%
12.36%
18.86%
22.90%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
Other Income
56.80
68.70
38.30
11.29
17.64
47.43
35.74
40.03
24.86
13.37
42.45
Interest
240.30
272.30
188.20
145.49
184.10
287.41
219.81
284.28
341.11
371.35
367.61
Depreciation
368.60
381.90
554.00
381.70
348.95
461.93
370.90
415.05
291.40
346.74
287.95
PBT
981.10
315.30
72.30
640.43
881.05
1,245.17
1,184.04
859.08
737.64
542.22
88.43
Tax
144.30
97.80
92.70
217.43
297.22
312.29
326.80
224.66
163.02
155.40
80.48
Tax Rate
14.71%
66.80%
598.06%
33.95%
34.57%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
PAT
836.80
77.10
-61.00
413.94
562.87
898.24
574.46
642.81
575.66
391.83
-57.76
PAT before Minority Interest
839.90
72.70
-64.90
413.02
562.61
898.24
577.01
634.42
574.63
386.82
-40.16
Minority Interest
3.10
4.40
3.90
0.92
0.26
0.00
-2.55
8.39
1.03
5.01
-17.60
PAT Margin
11.57%
1.15%
-0.97%
6.75%
9.23%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
PAT Growth
1,621.81%
-
-
-26.46%
-37.34%
56.36%
-10.63%
11.66%
46.92%
-
 
EPS
52.53
4.84
-3.83
25.98
35.33
56.39
36.06
40.35
36.14
24.60
-3.63

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
5,433.90
5,399.30
5,318.56
4,741.49
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
Share Capital
15.80
15.90
15.92
15.92
15.93
15.93
15.58
15.57
15.54
15.93
Total Reserves
5,403.60
5,377.20
5,298.98
4,724.75
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
Non-Current Liabilities
4,005.70
3,765.00
2,921.59
2,973.05
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
Secured Loans
299.30
265.10
200.94
20.78
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
Unsecured Loans
2,867.80
2,845.30
2,263.30
2,543.19
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
Long Term Provisions
100.10
92.20
95.67
94.01
150.75
114.35
107.08
80.69
70.31
67.04
Current Liabilities
1,889.00
1,772.40
1,591.60
1,048.83
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
Trade Payables
856.30
821.30
567.74
520.48
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
Other Current Liabilities
732.80
552.10
838.52
371.73
674.21
473.57
505.87
572.70
951.43
793.31
Short Term Borrowings
196.50
258.30
64.00
20.00
649.89
499.71
244.85
255.60
748.97
517.17
Short Term Provisions
103.40
140.70
121.34
136.62
204.64
96.31
117.81
106.24
151.93
97.49
Total Liabilities
11,315.80
10,929.20
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
Net Block
5,091.20
5,183.30
4,870.61
4,608.75
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
Gross Block
7,868.90
7,368.00
6,758.89
6,089.57
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
Accumulated Depreciation
2,777.70
2,184.70
1,888.28
1,480.83
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
Non Current Assets
7,439.70
7,166.80
6,320.40
5,810.90
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
Capital Work in Progress
2,103.10
1,561.50
1,089.57
896.99
768.39
901.43
670.97
683.78
611.32
596.60
Non Current Investment
42.20
256.40
238.60
240.96
69.36
115.11
123.52
102.71
85.43
39.50
Long Term Loans & Adv.
191.90
161.50
117.64
62.84
86.81
68.59
71.79
56.32
62.67
327.17
Other Non Current Assets
11.30
4.10
3.98
1.35
7.53
0.66
0.58
1.08
0.53
29.68
Current Assets
3,632.20
3,762.40
3,509.19
2,952.50
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,289.60
1,380.50
1,254.87
1,129.38
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
Sundry Debtors
915.90
961.20
927.99
819.90
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
Cash & Bank
956.80
1,014.30
984.24
671.32
1,399.87
1,370.41
248.79
459.63
344.58
394.34
Other Current Assets
469.90
135.10
110.93
242.37
499.88
525.44
418.81
262.79
377.13
265.59
Short Term Loans & Adv.
228.00
271.30
231.17
89.53
80.29
39.80
45.75
37.06
133.06
144.56
Net Current Assets
1,743.20
1,990.00
1,917.59
1,903.67
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
Total Assets
11,071.90
10,929.20
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
971.30
660.70
837.54
1,784.27
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
PBT
170.50
27.80
630.45
1,212.01
1,210.53
903.81
859.08
737.64
542.22
40.32
Adjustment
755.40
782.90
579.47
716.48
760.74
861.53
687.81
637.90
737.89
725.84
Changes in Working Capital
253.10
54.30
-178.29
249.90
-179.67
-300.53
14.15
36.88
-133.16
96.40
Cash after chg. in Working capital
1,179.00
865.00
1,031.63
2,178.39
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-207.70
-204.30
-194.09
-394.12
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-607.90
-544.40
-380.37
-739.01
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
Net Fixed Assets
-51.10
-92.16
-752.97
2,198.22
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
Net Investments
-0.30
-10.85
0.23
118.05
-0.14
-57.59
3.34
-0.39
57.01
239.81
Others
-556.50
-441.39
372.37
-3,055.28
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
Cash from Financing Activity
-432.50
-156.70
-32.60
-1,709.39
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
Net Cash Inflow / Outflow
-69.10
-40.40
424.57
-664.13
165.56
767.10
-215.63
132.22
-56.38
-62.76
Opening Cash & Equivalents
1,013.90
983.80
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.64
473.49
Closing Cash & Equivalent
956.40
1,013.90
983.82
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.63

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
343.00
339.19
333.91
297.84
351.83
301.93
262.33
220.61
190.90
154.04
ROA
0.65%
-0.63%
4.44%
5.34%
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
ROE
1.34%
-1.21%
8.21%
10.88%
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
ROCE
5.02%
2.53%
9.97%
11.89%
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
Fixed Asset Turnover
0.88
0.89
0.95
0.87
1.23
1.38
1.26
1.09
0.92
0.81
Receivable days
51.11
54.89
52.04
63.24
51.13
48.12
51.58
59.43
54.81
49.56
Inventory Days
72.70
76.56
70.98
89.02
65.05
56.26
63.07
73.64
75.51
78.58
Payable days
143.02
134.99
133.47
191.38
58.75
55.42
56.86
54.84
53.44
52.17
Cash Conversion Cycle
-19.21
-3.54
-10.45
-39.12
57.43
48.96
57.79
78.23
76.88
75.98
Total Debt/Equity
0.63
0.63
0.55
0.55
0.83
1.01
0.85
1.18
1.51
1.95
Interest Cover
1.63
1.15
5.33
5.67
5.21
5.11
4.02
3.16
2.46
1.11

News Update:


  • Jubilant Pharmova gets nod to sell, transfer API business to Jubilant Biosys
    13th Jun 2025, 12:21 PM

    The board of directors of the company in their meeting held on June 12, 2025 has approved the same

    Read More
  • Jubilant Pharmova’s arm inks Shareholders’ Agreement with Pierre Fabre SA
    20th Mar 2025, 14:59 PM

    The name of JASMIN has been changed to ‘Jubilant Biosys France’ which is now a subsidiary of JBIRSPL

    Read More
  • Jubilant Pharmova's arm gets EIR with VAI status for Maryland facility
    13th Mar 2025, 10:59 AM

    With the receipt of the EIR from the USFDA, the inspection stands successfully closed

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.